Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Honeywell International Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Honeywell International Inc trades at $208.12 (market cap $65.80B). The key difference: Honeywell International Inc is far larger — about 7.8× Hinge Health Inc. Class A Common Stock's market cap, and Honeywell International Inc pays a 1.35% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Honeywell International Inc for 91 Days on average.
| HNGE | HON | |
|---|---|---|
Market Cap | $8.47B | $65.80B |
Volume | 1,624,526 | 2,982,982 |
Sector | Health | Industrials |
52-Week High | $105.14 | $248.79 |
52-Week Low | $31.17 | $188.14 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $8.09B | $90.59B |
Dividend Yield | — | 1.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Honeywell International (HON) trades at $207.29, down 1.12% on the day, with bearish technical signals but strong fundamental metrics including a low P/E of 7.97 and robust ROE of 47.43%. The company recently completed its transformation into a pure-play automation business following spin-offs and secured a significant $300 million refinery project with Dangote. Earnings have consistently beaten expectations in recent quarters, with Q3 2026 results expected on October 22.
HON presents a compelling value opportunity with attractive valuation multiples and strong profitability, though near-term technical weakness and increasing debt levels warrant caution. Analyst consensus remains strongly bullish with a $259.25 price target representing 25% upside potential. The company's refocused automation strategy and recent contract wins provide growth catalysts, while execution risks and macroeconomic sensitivity pose challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
